Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.

Identifieur interne : 000267 ( PubMed/Curation ); précédent : 000266; suivant : 000268

Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.

Auteurs : K. Mehta [Canada] ; L W Goneau [Canada] ; J. Wong [Canada] ; A G L'Huillier [Canada] ; J B Gubbay [Canada]

Source :

RBID : pubmed:30069787

Abstract

Zoonotic influenza viruses are those influenza viruses that cross the animal-human barrier and can cause disease in humans, manifesting from minor respiratory illnesses to multiorgan dysfunction. The increasing incidence of infections caused by these viruses worldwide has necessitated focused attention to improve both diagnostic as well as treatment modalities. In this second part of a two-part review, we discuss the clinical features, diagnostic modalities, and treatment of zoonotic influenza, and provide an overview of prevention strategies.

DOI: 10.1007/s11908-018-0643-8
PubMed: 30069787

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:30069787

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.</title>
<author>
<name sortKey="Mehta, K" sort="Mehta, K" uniqKey="Mehta K" first="K" last="Mehta">K. Mehta</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Goneau, L W" sort="Goneau, L W" uniqKey="Goneau L" first="L W" last="Goneau">L W Goneau</name>
<affiliation wicri:level="1">
<nlm:affiliation>Public Health Ontario, 661 University Avenue, Toronto, Ontario, M5G 1M1, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Public Health Ontario, 661 University Avenue, Toronto, Ontario, M5G 1M1</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wong, J" sort="Wong, J" uniqKey="Wong J" first="J" last="Wong">J. Wong</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="L Huillier, A G" sort="L Huillier, A G" uniqKey="L Huillier A" first="A G" last="L'Huillier">A G L'Huillier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gubbay, J B" sort="Gubbay, J B" uniqKey="Gubbay J" first="J B" last="Gubbay">J B Gubbay</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. jonathan.gubbay@oahpp.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:30069787</idno>
<idno type="pmid">30069787</idno>
<idno type="doi">10.1007/s11908-018-0643-8</idno>
<idno type="wicri:Area/PubMed/Corpus">000267</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000267</idno>
<idno type="wicri:Area/PubMed/Curation">000267</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000267</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.</title>
<author>
<name sortKey="Mehta, K" sort="Mehta, K" uniqKey="Mehta K" first="K" last="Mehta">K. Mehta</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Goneau, L W" sort="Goneau, L W" uniqKey="Goneau L" first="L W" last="Goneau">L W Goneau</name>
<affiliation wicri:level="1">
<nlm:affiliation>Public Health Ontario, 661 University Avenue, Toronto, Ontario, M5G 1M1, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Public Health Ontario, 661 University Avenue, Toronto, Ontario, M5G 1M1</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wong, J" sort="Wong, J" uniqKey="Wong J" first="J" last="Wong">J. Wong</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="L Huillier, A G" sort="L Huillier, A G" uniqKey="L Huillier A" first="A G" last="L'Huillier">A G L'Huillier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gubbay, J B" sort="Gubbay, J B" uniqKey="Gubbay J" first="J B" last="Gubbay">J B Gubbay</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. jonathan.gubbay@oahpp.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Current infectious disease reports</title>
<idno type="ISSN">1523-3847</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Zoonotic influenza viruses are those influenza viruses that cross the animal-human barrier and can cause disease in humans, manifesting from minor respiratory illnesses to multiorgan dysfunction. The increasing incidence of infections caused by these viruses worldwide has necessitated focused attention to improve both diagnostic as well as treatment modalities. In this second part of a two-part review, we discuss the clinical features, diagnostic modalities, and treatment of zoonotic influenza, and provide an overview of prevention strategies.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">30069787</PMID>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">1523-3847</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2018</Year>
<Month>Aug</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Current infectious disease reports</Title>
<ISOAbbreviation>Curr Infect Dis Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.</ArticleTitle>
<Pagination>
<MedlinePgn>38</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11908-018-0643-8</ELocationID>
<Abstract>
<AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Zoonotic influenza viruses are those influenza viruses that cross the animal-human barrier and can cause disease in humans, manifesting from minor respiratory illnesses to multiorgan dysfunction. The increasing incidence of infections caused by these viruses worldwide has necessitated focused attention to improve both diagnostic as well as treatment modalities. In this second part of a two-part review, we discuss the clinical features, diagnostic modalities, and treatment of zoonotic influenza, and provide an overview of prevention strategies.</AbstractText>
<AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Illnesses caused by novel reassortant avian influenza viruses continue to be detected and described; most recently, a human case of avian influenza A(H7N4) has been described from China. We continue to witness increasing rates of A(H7N9) infections, with the latest (fifth) wave, from late 2016 to 2017, being the largest to date. The case fatality rate for A(H7N9) and A(H5N1) infections among humans is much higher than that of seasonal influenza infections. Since the emergence of the A(H1N1) 2009 pandemic, and subsequently A(H7N9), testing and surveillance for novel influenzas have become more effective. Various newer treatment options, including peramivir, favipiravir (T-705), and DAS181, and human or murine monoclonal antibodies have been evaluated in vitro and in animal models. Armed with robust diagnostic modalities, antiviral medications, vaccines, and advanced surveillance systems, we are today better prepared to face a new influenza pandemic and to limit the burden of zoonotic influenza than ever before. Sustained efforts and robust research are necessary to efficiently deal with the highly mutagenic zoonotic influenza viruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mehta</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goneau</LastName>
<ForeName>L W</ForeName>
<Initials>LW</Initials>
<AffiliationInfo>
<Affiliation>Public Health Ontario, 661 University Avenue, Toronto, Ontario, M5G 1M1, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of Toronto, 27 King's College Circle, Toronto, Ontario, M5S 1A1, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wong</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Paediatrics, North York General Hospital, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>L'Huillier</LastName>
<ForeName>A G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gubbay</LastName>
<ForeName>J B</ForeName>
<Initials>JB</Initials>
<AffiliationInfo>
<Affiliation>Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. jonathan.gubbay@oahpp.ca.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Public Health Ontario, 661 University Avenue, Toronto, Ontario, M5G 1M1, Canada. jonathan.gubbay@oahpp.ca.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of Toronto, 27 King's College Circle, Toronto, Ontario, M5S 1A1, Canada. jonathan.gubbay@oahpp.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>08</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Curr Infect Dis Rep</MedlineTA>
<NlmUniqueID>100888983</NlmUniqueID>
<ISSNLinking>1523-3847</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Avian influenza</Keyword>
<Keyword MajorTopicYN="N">Pandemic</Keyword>
<Keyword MajorTopicYN="N">Swine influenza</Keyword>
<Keyword MajorTopicYN="N">Zoonotic influenza</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>8</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">30069787</ArticleId>
<ArticleId IdType="doi">10.1007/s11908-018-0643-8</ArticleId>
<ArticleId IdType="pii">10.1007/s11908-018-0643-8</ArticleId>
<ArticleId IdType="pmc">PMC7102074</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Infect. 2014 Sep;69(3):297-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24680866</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2008 May 1;197(9):1315-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18422444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(1):e31006</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22292088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Feb 21;363(9409):617-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14987888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2007 Jan;7(1):21-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17182341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Wkly Epidemiol Rec. ;92(33):460-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28819964</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2012 Nov;206(9):1359-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22927451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Jun 15;193(12):1626-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16703504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2005 Dec 22;353(25):2667-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16371632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Res Int. 2014;2014:653056</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25057497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunotherapy. 2016 Sep;8(9):1021-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27380317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2005 Sep 29;353(13):1374-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16192482</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interferon Cytokine Res. 2011 Jun;31(6):515-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21323570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2013 Sep;51(9):3160-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23784125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2004 Jul 8;430(6996):209-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15241415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 May 25;6:26742</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27221530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2013 Jun 29;381(9885):2273-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23726392</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2004 Feb 21;363(9409):587-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14987882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2013;19(9):1521-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23965618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2007 Apr;7(4):267-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17363960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2005 Feb;11(2):201-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15752436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2012 Apr;25(2):223-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22491771</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2005 Oct 20;437(7062):1108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16228009</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2006 Jan 28;367(9507):303-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16443037</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 May 16;368(20):1888-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23577628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1993 Sep;67(9):5585-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7688826</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2007 Apr;51(4):1414-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17296744</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Anti Infect Ther. 2010 May;8(5):517-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20455681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Jul 12;28(31):4895-902</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20553769</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Feb 6;370(6):520-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23614499</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 Aug 1;210(3):435-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24569063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zoonoses Public Health. 2014 Feb;61(1):4-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23556412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Pharmacother. 2009 Dec;43(12):2001-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19920156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 Jun 13;368(24):2277-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23697469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microb Pathog. 2016 Feb;91:35-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26639679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 Aug 15;59(4):604-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24795330</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 Dec 15;210(12):1900-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24951824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Nov 23;355(21):2186-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17124016</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 May 1;209(9):1343-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24133191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2007;12(3):363-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17591026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2007 Sep;13(9):1354-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18252107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Infect Dis. 2015 Dec;41:3-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26482389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 Jan 15;211(2):249-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25124927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2016 Nov;135:48-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27713074</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Dec 23;4(12):e8431</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20037716</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2015 Jan;96(Pt 1):46-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25274854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2008 Apr 26;371(9622):1464-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18440429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21692672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2015 Feb 06;15:44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25656393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbes Infect. 2013 Jun;15(6-7):432-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23628410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2009 Jan;137(1):1-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18700992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Microbes Infect. 2014 Nov;3(11):e78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26038501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2845-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16473931</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2013 Dec;19(12):1963-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24274711</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2005 Aug 15;192(4):665-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16028136</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Mol Diagn. 2014 May;14(4):411-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24707995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2006 Sep;44(9):3366-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16954274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2012 Sep 14;61(36):726-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22971746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Oct 15;202(8):1154-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20831384</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2009 Aug 15;200(4):510-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19591579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2017 Jan 15;228:109-113</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27914930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Recomm Rep. 2017 Aug 25;66(2):1-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28841201</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2015 Mar;15(3):285-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25662592</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Mar 5;360(10):953-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19258250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):10890-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26283346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Anti Infect Ther. 2017 Aug;15(8):723-727</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28692316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Jan 17;358(3):261-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18199865</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2009 Sep;3(5):207-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19768134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 1999 Sep 11;354(9182):916-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10489954</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2009 Jun 15;48(12):1639-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19435433</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Genet Evol. 2009 Mar;9(2):169-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19022400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Chem Chemother. 2014 Dec 16;23(6):237-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23948557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Viruses. 2016 Apr 12;8(4):96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27077877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2013 Jun 1;381(9881):1916-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23623390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1356-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14745020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2005 Feb;86(Pt 2):423-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15659762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2001 Mar;63(3):242-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11170064</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Sci. 1994 Oct;3(10):1687-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7849585</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 Apr;58(8):1095-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24488975</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2010 Aug;84(16):8042-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20519385</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2007 Apr 15;44(8):1084-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17366454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2017 Aug;17(8):822-832</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28583578</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Sep 26;501(7468):551-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23842494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2013 Jun 29;381(9885):2230-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23809549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000267 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000267 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:30069787
   |texte=   Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:30069787" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021